Arce, VF, Furness, AJS, Litchfield, K, Joshi, K, Rosenthal, R, Ghorani, E, Solomon, I, Lesko, MH, Ruef, N, Roddie, C, Henry, JY, Spain, L, Ben, AA, Georgiou, A, Wong, YNS, Smith, M, Strauss, D, Hayes, A, Nicol, D, O'Brien, T, Mårtensson, L, Ljungars, A, Teige, I, Frendéus, B, Pule, M, Marafioti, T, Gore, M, Larkin, J, Turajlic, S, Swanton, C, Peggs, KS, Quezada, SA, Harrington, K, Melcher, A, Wotherspoon, A, Francis, N, Challacombe, B, Fernando, A, Hazell, S, Chandra, A, Pickering, L, Lynch, J, Rudman, S, Chowdhury, S, Harrison-Phipps, K, Varia, M, Horsfield, C, Polson, A, Stamp, G, O'Donnell, M, Drake, W, Hill, P, Hrouda, D, Mayer, E, Olsburgh, J, Kooiman, G, O'Connor, K, Stewart, G, Aitchison, M, Tran, M, Fotiadis, N, Verma, H, Lopez, J, Lester, J, Morgan, F, Kornaszewska, M, Attanoos, R, Adams, H, Davies, H, Fennell, D, Shaw, J, Le, QJ, Nakas, A, Rathinam, S, Monteiro, W, Marshall, H, Nelson, L
, Bennett, J, Riley, J, Primrose, L, Martinson, L, Anand, G, Khan, S, Nicolson, M, Kerr, K, Palmer, S, Remmen, H, Miller, J, Buchan, K, Chetty, M, Gomersall, L & Loc 2018, '
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies',
Cancer Cell, vol. 33, no. 4, pp. 649-663.e4.
https://doi.org/10.1016/j.ccell.2018.02.010